HFE mutations in α-1-antitrypsin deficiency: An examination of cirrhotic explants

Maggie Lam, Michael Torbenson, Matthew M. Yeh, Perumal Vivekanandan, Linda Ferrell

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Increased iron deposition is often seen in liver explants with α-1-antitrypsin deficiency, but it remains unclear if this is a nonspecific effect of end-stage liver disease or if individuals with α-1-antitrypsin deficiency and excess iron are at increased risk for HFE mutations. To further examine this question, 45 liver explants with α-1-antitrypsin deficiency and 33 control livers with chronic hepatitis C were examined for histological iron accumulation, graded on a scale of 0 to 4, and HFE mutations. Interestingly, the α-1-antitrypsin cirrhotic livers showed a bimodal distribution of iron accumulation, with peaks at grades 1 and 3. In contrast, hepatitis C cirrhotic livers showed a unimodal distribution with a peak at grade 2. HFE mutations in livers with α-1-antitrypsin deficiency were as follows: C282Y2%, H63D42%. H63D mutations were more frequent in α-1-antitrypsin deficiency cases than in controls (42 vs 27%), but was not statistically significant, P0.17. However, there was a significant association with HFE mutations in α-1-antitrypsin deficiency livers with grade 3 or 4 iron, P0.02. In contrast, livers with hepatitis C showed a similar frequency of HFE mutations as the general population: C282Y15%, H63D27%. A rare S65C mutation and a novel A271S mutation were also found in this study; the latter patient had 4 iron in the liver and later developed heart failure with cardiac iron. In conclusion, total H63D mutations were high (42%) in cirrhotics with α-1-antitrypsin deficiency and there was a significant association between HFE mutations and high levels of iron accumulation.

Original languageEnglish (US)
Pages (from-to)637-643
Number of pages7
JournalModern Pathology
Volume23
Issue number5
DOIs
StatePublished - May 1 2010
Externally publishedYes

Fingerprint

Iron
Mutation
Liver
Hepatitis C
End Stage Liver Disease
Chronic Hepatitis C
Mutation Rate
Heart Failure
Population

Keywords

  • A-1-antitrypsin deficiency
  • C282Y
  • Cirrhosis
  • H63D
  • Hemochromatosis
  • HFE mutation

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

HFE mutations in α-1-antitrypsin deficiency : An examination of cirrhotic explants. / Lam, Maggie; Torbenson, Michael; Yeh, Matthew M.; Vivekanandan, Perumal; Ferrell, Linda.

In: Modern Pathology, Vol. 23, No. 5, 01.05.2010, p. 637-643.

Research output: Contribution to journalArticle

Lam, Maggie ; Torbenson, Michael ; Yeh, Matthew M. ; Vivekanandan, Perumal ; Ferrell, Linda. / HFE mutations in α-1-antitrypsin deficiency : An examination of cirrhotic explants. In: Modern Pathology. 2010 ; Vol. 23, No. 5. pp. 637-643.
@article{751d7bce2ef54f3ab80a41bf498628a7,
title = "HFE mutations in α-1-antitrypsin deficiency: An examination of cirrhotic explants",
abstract = "Increased iron deposition is often seen in liver explants with α-1-antitrypsin deficiency, but it remains unclear if this is a nonspecific effect of end-stage liver disease or if individuals with α-1-antitrypsin deficiency and excess iron are at increased risk for HFE mutations. To further examine this question, 45 liver explants with α-1-antitrypsin deficiency and 33 control livers with chronic hepatitis C were examined for histological iron accumulation, graded on a scale of 0 to 4, and HFE mutations. Interestingly, the α-1-antitrypsin cirrhotic livers showed a bimodal distribution of iron accumulation, with peaks at grades 1 and 3. In contrast, hepatitis C cirrhotic livers showed a unimodal distribution with a peak at grade 2. HFE mutations in livers with α-1-antitrypsin deficiency were as follows: C282Y2{\%}, H63D42{\%}. H63D mutations were more frequent in α-1-antitrypsin deficiency cases than in controls (42 vs 27{\%}), but was not statistically significant, P0.17. However, there was a significant association with HFE mutations in α-1-antitrypsin deficiency livers with grade 3 or 4 iron, P0.02. In contrast, livers with hepatitis C showed a similar frequency of HFE mutations as the general population: C282Y15{\%}, H63D27{\%}. A rare S65C mutation and a novel A271S mutation were also found in this study; the latter patient had 4 iron in the liver and later developed heart failure with cardiac iron. In conclusion, total H63D mutations were high (42{\%}) in cirrhotics with α-1-antitrypsin deficiency and there was a significant association between HFE mutations and high levels of iron accumulation.",
keywords = "A-1-antitrypsin deficiency, C282Y, Cirrhosis, H63D, Hemochromatosis, HFE mutation",
author = "Maggie Lam and Michael Torbenson and Yeh, {Matthew M.} and Perumal Vivekanandan and Linda Ferrell",
year = "2010",
month = "5",
day = "1",
doi = "10.1038/modpathol.2010.42",
language = "English (US)",
volume = "23",
pages = "637--643",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - HFE mutations in α-1-antitrypsin deficiency

T2 - An examination of cirrhotic explants

AU - Lam, Maggie

AU - Torbenson, Michael

AU - Yeh, Matthew M.

AU - Vivekanandan, Perumal

AU - Ferrell, Linda

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Increased iron deposition is often seen in liver explants with α-1-antitrypsin deficiency, but it remains unclear if this is a nonspecific effect of end-stage liver disease or if individuals with α-1-antitrypsin deficiency and excess iron are at increased risk for HFE mutations. To further examine this question, 45 liver explants with α-1-antitrypsin deficiency and 33 control livers with chronic hepatitis C were examined for histological iron accumulation, graded on a scale of 0 to 4, and HFE mutations. Interestingly, the α-1-antitrypsin cirrhotic livers showed a bimodal distribution of iron accumulation, with peaks at grades 1 and 3. In contrast, hepatitis C cirrhotic livers showed a unimodal distribution with a peak at grade 2. HFE mutations in livers with α-1-antitrypsin deficiency were as follows: C282Y2%, H63D42%. H63D mutations were more frequent in α-1-antitrypsin deficiency cases than in controls (42 vs 27%), but was not statistically significant, P0.17. However, there was a significant association with HFE mutations in α-1-antitrypsin deficiency livers with grade 3 or 4 iron, P0.02. In contrast, livers with hepatitis C showed a similar frequency of HFE mutations as the general population: C282Y15%, H63D27%. A rare S65C mutation and a novel A271S mutation were also found in this study; the latter patient had 4 iron in the liver and later developed heart failure with cardiac iron. In conclusion, total H63D mutations were high (42%) in cirrhotics with α-1-antitrypsin deficiency and there was a significant association between HFE mutations and high levels of iron accumulation.

AB - Increased iron deposition is often seen in liver explants with α-1-antitrypsin deficiency, but it remains unclear if this is a nonspecific effect of end-stage liver disease or if individuals with α-1-antitrypsin deficiency and excess iron are at increased risk for HFE mutations. To further examine this question, 45 liver explants with α-1-antitrypsin deficiency and 33 control livers with chronic hepatitis C were examined for histological iron accumulation, graded on a scale of 0 to 4, and HFE mutations. Interestingly, the α-1-antitrypsin cirrhotic livers showed a bimodal distribution of iron accumulation, with peaks at grades 1 and 3. In contrast, hepatitis C cirrhotic livers showed a unimodal distribution with a peak at grade 2. HFE mutations in livers with α-1-antitrypsin deficiency were as follows: C282Y2%, H63D42%. H63D mutations were more frequent in α-1-antitrypsin deficiency cases than in controls (42 vs 27%), but was not statistically significant, P0.17. However, there was a significant association with HFE mutations in α-1-antitrypsin deficiency livers with grade 3 or 4 iron, P0.02. In contrast, livers with hepatitis C showed a similar frequency of HFE mutations as the general population: C282Y15%, H63D27%. A rare S65C mutation and a novel A271S mutation were also found in this study; the latter patient had 4 iron in the liver and later developed heart failure with cardiac iron. In conclusion, total H63D mutations were high (42%) in cirrhotics with α-1-antitrypsin deficiency and there was a significant association between HFE mutations and high levels of iron accumulation.

KW - A-1-antitrypsin deficiency

KW - C282Y

KW - Cirrhosis

KW - H63D

KW - Hemochromatosis

KW - HFE mutation

UR - http://www.scopus.com/inward/record.url?scp=77952012348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952012348&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2010.42

DO - 10.1038/modpathol.2010.42

M3 - Article

C2 - 20208481

AN - SCOPUS:77952012348

VL - 23

SP - 637

EP - 643

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 5

ER -